Last reviewed · How we verify

Adverse Reactions of Botox subdermally

ASIS Corporation · Phase 1 active Small molecule

Adverse Reactions of Botox subdermally is a Small molecule drug developed by ASIS Corporation. It is currently in Phase 1 development. Also known as: Botox (onabotulinumtoxinA).

At a glance

Generic nameAdverse Reactions of Botox subdermally
Also known asBotox (onabotulinumtoxinA)
SponsorASIS Corporation
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Adverse Reactions of Botox subdermally

What is Adverse Reactions of Botox subdermally?

Adverse Reactions of Botox subdermally is a Small molecule drug developed by ASIS Corporation.

Who makes Adverse Reactions of Botox subdermally?

Adverse Reactions of Botox subdermally is developed by ASIS Corporation (see full ASIS Corporation pipeline at /company/asis-corporation).

Is Adverse Reactions of Botox subdermally also known as anything else?

Adverse Reactions of Botox subdermally is also known as Botox (onabotulinumtoxinA).

What development phase is Adverse Reactions of Botox subdermally in?

Adverse Reactions of Botox subdermally is in Phase 1.

Related